Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Efficacy and Tolerability Between 2fixed Combinations for Treating Mexican Patients With Primary Open-Angle Glaucoma or Ocular Hypertension: Ganforti vs Krytantek.A Phase IV,Examiner-masked Cross-over Multicenter Clinical Trial

NCT01737853 is registered in ClinicalTrials.gov with Allergan S.A. DE C.V.. as lead sponsor.

NCT NCT01737853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01737853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Efficacy and Tolerability Between 2fixed Combinations for Treating Mexican Patients With Primary Open-Angle Glaucoma or Ocular Hypertension: Ganforti vs Krytantek.A Phase IV,Examiner-masked Cross-over Multicenter Clinical Trial
Lead sponsor
Allergan S.A. DE C.V..
Phase
Observational
Overall status
Completed
Start date
February 28, 2011
Completion date
June 30, 2012
Enrollment
90 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma primary open angle